Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Biogen Idec and Elan submit applications for first-line use of Tysabri in anti-JCV antibody negative patients with MS
The Spectrum of Neuromyelitis Optica (NMO) in Childhood.
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation.
T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
The origins of multiple sclerosis: a synthesis
Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis.
Low dose naltrexone for induction of remission in Crohn's disease.
Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis.
Brain imaging and bladder function.
A cluster randomised controlled trial on the efficacy of client-centred occupational therapy in multiple sclerosis: good process, poor outcome.
Animal assisted interventions in neurorehabilitation: A review of the most recent literature.
Biomarkers in Multiple Sclerosis: An Up-to-Date Overview.
Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis.
Development of nucleic acid drugs for neurological disorders.
Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.
Citrullination of Histone H3 Interferes with HP1-Mediated Transcriptional Repression.
Sexual Behavior, Body Image, and Partnership in Chronic Illness: A Comparison of Huntington's Disease and Multiple Sclerosis.
Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
Analysis of CD4+CD8+ double positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions.
Smoking and Risk of Multiple Sclerosis: Evidence of Modification by NAT1 Variants.
Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study.
Cost of disorders of the brain in Spain.
Effects of vitamin d3, calcipotriol and FTY720 on the expression of surface molecules and cytolytic activities of human natural killer cells and dendritic cells.
Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis.
Journal Club: Intrathecal effects of daclizumab treatment of multiple sclerosis.

Pages